VYGR: Voyager Therapeutics, Inc. Stock

by  •  • Comments Off on VYGR: Voyager Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 339.77
Enterprise Value ($M) 227.25
Book Value ($M) 330.31
Book Value / Share 6.05
Price / Book 1.03
NCAV ($M) 277.71
NCAV / Share 5.08
Price / NCAV 1.22

Profitability (mra)
Return on Invested Capital (ROIC) 0.07
Return on Assets (ROA) 0.09
Return on Equity (ROE) 0.15

Liquidity (mrq)
Quick Ratio 8.45
Current Ratio 8.45

Balance Sheet (mrq) ($M)
Current Assets 373.44
Assets 426.04
Liabilities 95.73
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
3 days ago 13G/A Armistice Capital, Llc 9.54 22.76
3 days ago 13G/A EcoR1 Capital, LLC 9.99 45.86
08-07 13G/A BlackRock, Inc. 10.00 107.39
02-14 13G/A Third Rock Ventures III, L.P. 0.40 -96.59
02-13 13G/A Vanguard Group Inc 5.75 29.38

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-28 10-K UNITED STATES

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 166,725 743,427 22.43
2024-11-14 128,813 650,113 19.81
2024-11-13 122,938 639,315 19.23
2024-11-12 81,325 448,309 18.14
2024-11-11 49,048 443,307 11.06

(click for more detail)

Similar Companies
VRTX – Vertex Pharmaceuticals Incorporated VTRS – Viatris Inc.
VTYX – Ventyx Biosciences, Inc. XBIT – XBiotech Inc.
XERS – Xeris Biopharma Holdings, Inc.


Financial data and stock pages provided by
Fintel.io